Allspring Global Investments Holdings LLC Acquires 104,419 Shares of Dolby Laboratories, Inc. (NYSE:DLB)

Allspring Global Investments Holdings LLC grew its holdings in shares of Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 10,441,900.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 104,420 shares of the electronics maker's stock after purchasing an additional 104,419 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.11% of Dolby Laboratories worth $8,123,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in DLB. Boston Trust Walden Corp lifted its holdings in shares of Dolby Laboratories by 185.3% during the third quarter. Boston Trust Walden Corp now owns 1,075,076 shares of the electronics maker's stock valued at $82,276,000 after purchasing an additional 698,283 shares during the last quarter. Clifford Capital Partners LLC lifted its holdings in shares of Dolby Laboratories by 3,114.7% during the third quarter. Clifford Capital Partners LLC now owns 270,579 shares of the electronics maker's stock valued at $20,707,000 after purchasing an additional 262,162 shares during the last quarter. Thrivent Financial for Lutherans lifted its holdings in shares of Dolby Laboratories by 496.7% during the third quarter. Thrivent Financial for Lutherans now owns 102,223 shares of the electronics maker's stock valued at $7,823,000 after purchasing an additional 85,093 shares during the last quarter. Disciplined Growth Investors Inc. MN lifted its holdings in shares of Dolby Laboratories by 4.5% during the third quarter. Disciplined Growth Investors Inc. MN now owns 1,466,212 shares of the electronics maker's stock valued at $112,209,000 after purchasing an additional 63,589 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Dolby Laboratories by 4.3% during the third quarter. Geode Capital Management LLC now owns 1,538,583 shares of the electronics maker's stock valued at $117,767,000 after purchasing an additional 63,293 shares during the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on DLB. StockNews.com lowered shares of Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a report on Friday, January 31st. Rosenblatt Securities restated a "buy" rating and issued a $100.00 price objective on shares of Dolby Laboratories in a report on Thursday, January 30th. Finally, Barrington Research restated an "outperform" rating and issued a $100.00 price objective on shares of Dolby Laboratories in a report on Thursday, February 13th.

Dolby Laboratories Price Performance

NYSE DLB traded down $0.90 during mid-day trading on Friday, reaching $81.42. The stock had a trading volume of 646,093 shares, compared to its average volume of 481,486. Dolby Laboratories, Inc. has a 1 year low of $66.35 and a 1 year high of $89.66. The stock has a market cap of $7.77 billion, a PE ratio of 29.94 and a beta of 0.98. The company has a fifty day moving average price of $80.56 and a 200 day moving average price of $76.25.

Dolby Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 19th. Investors of record on Tuesday, February 11th were issued a $0.33 dividend. The ex-dividend date of this dividend was Tuesday, February 11th. This represents a $1.32 dividend on an annualized basis and a yield of 1.62%. Dolby Laboratories's payout ratio is currently 48.53%.

Insider Buying and Selling

In other Dolby Laboratories news, CAO Ryan Nicholson sold 10,500 shares of the business's stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $80.18, for a total transaction of $841,890.00. Following the completion of the sale, the chief accounting officer now directly owns 24,364 shares in the company, valued at approximately $1,953,505.52. The trade was a 30.12 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP John D. Couling sold 7,000 shares of the business's stock in a transaction on Monday, November 25th. The shares were sold at an average price of $80.50, for a total transaction of $563,500.00. Following the sale, the senior vice president now owns 106,806 shares of the company's stock, valued at approximately $8,597,883. This represents a 6.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 144,959 shares of company stock worth $11,897,065 in the last three months. Insiders own 38.39% of the company's stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.